Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fumoleau

Showing results (11-20 of 152) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2001
Docetaxel and cisplatin in head and neck cancerP Schöffski, J Wanders, J Verweij, et al.
Bulletin Du Cancer|August 1, 1995
[Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy]P Fumoleau, G Perrocheau, C Maugard-Louboutin, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
UFT plus oral calcium folinate/vinorelbine for advanced breast cancerP Fumoleau, R Déporte-Fety, P Kerbrat, et al.
Oncology (Williston Park, N.Y.)|June 1, 1997
Docetaxel combined with vinorelbine: phase I results and new study designsP Fumoleau, R Féty, V Delecroix, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
UFT/leucovorin plus vinorelbine combination for advanced breast cancerP Fumoleau, R Déporte, P Kerbrat, et al.
Bulletin Du Cancer|February 24, 2010
[Management of metastatic HER2-positive breast cancer: present and future]S Guiu, B Coudert, L Favier, et al.
Oral Oncology|February 12, 1998
Ondansetron suppository: an effective treatment for the prevention of emetic disorders induced by cisplatin-based chemotherapy. French Ondansetron Study GroupP Fumoleau, M Giovannini, F Rolland, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1983
[Comparison of the cardiotoxicity of adriamycin and aclacinomycin A in the rat. Optical and electron microscopic study]J B Bouhour, A Y Delajartre, S Chiffoleau, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancerP Kerbrat, V Dieras, N Pavlidis, et al.
Nuclear Medicine Communications|June 1, 1992
Anti-beta HCG abdominopelvic immunoscintigraphy in patients with resistant gestational trophoblastic diseaseJ Morais, P Peltier, J F Chatal, et al.
Pageof 16

Showing results (11-20 of 152) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2001
Docetaxel and cisplatin in head and neck cancerP Schöffski, J Wanders, J Verweij, et al.
Bulletin Du Cancer|August 1, 1995
[Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy]P Fumoleau, G Perrocheau, C Maugard-Louboutin, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
UFT plus oral calcium folinate/vinorelbine for advanced breast cancerP Fumoleau, R Déporte-Fety, P Kerbrat, et al.
Oncology (Williston Park, N.Y.)|June 1, 1997
Docetaxel combined with vinorelbine: phase I results and new study designsP Fumoleau, R Féty, V Delecroix, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
UFT/leucovorin plus vinorelbine combination for advanced breast cancerP Fumoleau, R Déporte, P Kerbrat, et al.
Bulletin Du Cancer|February 24, 2010
[Management of metastatic HER2-positive breast cancer: present and future]S Guiu, B Coudert, L Favier, et al.
Oral Oncology|February 12, 1998
Ondansetron suppository: an effective treatment for the prevention of emetic disorders induced by cisplatin-based chemotherapy. French Ondansetron Study GroupP Fumoleau, M Giovannini, F Rolland, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1983
[Comparison of the cardiotoxicity of adriamycin and aclacinomycin A in the rat. Optical and electron microscopic study]J B Bouhour, A Y Delajartre, S Chiffoleau, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancerP Kerbrat, V Dieras, N Pavlidis, et al.
Nuclear Medicine Communications|June 1, 1992
Anti-beta HCG abdominopelvic immunoscintigraphy in patients with resistant gestational trophoblastic diseaseJ Morais, P Peltier, J F Chatal, et al.
Pageof 16